Corinne H. Lyle

Director, Neurocrine Biosciences.

Companies

Insulet (United States)Board member Jan 29, 2019 to May 24, 2023¹
Neurocrine BiosciencesBoard member Jun 30, 2006 to May 25, 2018²
Onyx PharmaceuticalsBoard member Oct 10, 2006 to Oct 3, 2013³
Edwards LifesciencesCVP & Pres., Global Operations May 15, 2006 to May 17, 2010⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Insulet (United States) PODD6,010 shares⁵$849.7K at $141.38May 23, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 23, 2023Granted 843 shares of Insulet (United States)⁵
May 24, 2022Granted 1,009 shares of Insulet (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInsulet (United States), Board member
2
SEC EDGARNeurocrine Biosciences, Board member
3
SEC EDGAROnyx Pharmaceuticals, Board member
4
SEC EDGAREdwards Lifesciences, CVP & Pres., Global Operations
5
SEC EDGARInsulet (United States) shares after the filing of May 23, 2023
6
SEC EDGARForm 4 filed May 26, 2022